Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer
CONCLUSION: An original SIS from the PRO-CTCAE for patients with breast cancer were verified the validity, reliability, and responsiveness. Further studies to improve and validate the SIS are needed.PMID:37422608 | DOI:10.1007/s12282-023-01480-3
Source: Breast Cancer - Category: Cancer & Oncology Authors: Yoko Suzuki Takayuki Iwamoto Maya Uno Minami Hatono Yukiko Kajiwara Yuko Takahashi Mariko Kochi Tadahiko Shien Yuichiro Kikawa Yukari Uemura Yasuhiro Hagiwara Seiichiro Yamamoto Naruto Taira Hiroyoshi Doihara Shinichi Toyooka Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Docetaxel | Endocrine Therapy | Study | Taxotere